Indonesia vs Russian Federation: Number of clinical trials
Indonesia
88
in 2024
Russian Federation
96
in 2024
Indonesia rank
27th
Russian Federation rank
26th
Number of clinical trials over time
- Indonesia
- Russian Federation
How they compare
Russian Federation currently reports 96 against 88 in Indonesia, a difference of 8.
That makes Russian Federation's figure about 1.1 times Indonesia's.
Across all 21 years both countries report, Russian Federation has been ahead every year.
Indonesia ranks 27th and Russian Federation ranks 26th of 153 countries.
Russian Federation has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Indonesia | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.5 | 18.67 | 15.17 | Russian Federation |
| 2010s | 27.5 | 67.9 | 40.4 | Russian Federation |
| 2020s | 87 | 125.4 | 38.4 | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of clinical trials, Indonesia or Russian Federation?
- Russian Federation, at 96 against 88 in Indonesia as of 2024.
- What is the difference in number of clinical trials between Indonesia and Russian Federation?
- 8, with Russian Federation ahead.
- How many years of comparable data are there for Indonesia and Russian Federation?
- 21 years are reported by both, from 2004 to 2024.
- How do Indonesia and Russian Federation rank globally for number of clinical trials?
- Indonesia ranks 27th and Russian Federation ranks 26th of 153 countries.
- Where does this data come from?
- Our World in Data, published as Number of clinical trials. Statizoid refreshes it automatically from the source and publishes the full history for both places.